Table 2: Comparison of factors that affect the BMD.
|
|
Sex (n) |
Immunophenotype (n) |
ALL Risk Group (n) |
Age at diagnosis (n) |
Vitamin D supp.*** |
||||||
|
Male |
Female |
Pro-B |
Pre-B |
SRG |
IRG |
HRG |
< 7 years |
≥ 7 years |
Received |
Not received |
|
|
Normal |
6 |
15 |
3 |
18 |
9 |
10 |
3 |
15 |
6 |
17 |
4 |
|
Low bone density |
15 |
14 |
3 |
26 |
8 |
19 |
2 |
22 |
7 |
15 |
14 |
|
Osteoporosis |
5 |
3 |
2 |
6 |
1 |
6 |
0 |
5 |
3 |
2 |
6 |
|
P value |
0.055* |
0.728* |
0.149** |
0.856* |
0.004* |
||||||
ALL: Acute lymphoblastic leukemia; SRG: Standard risk group; IRG: Intermediate risk group; HRG: High risk group;
*Mann-whitney U test; **Kruskal wallis test; ***Vitamin D supplementation while under chemotherapy, p of significance if < 0.05.